Results 121 to 130 of about 24,471 (215)

Meningococcal vaccines [PDF]

open access: yesJournal of Medical Microbiology, 1993
openaire   +2 more sources

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

open access: yesInfection and Drug Resistance, 2011
Michael Bröker, Brian Cooper, Lisa M DeTora, Jeffrey J StoddardGlobal Medical Affairs, Novartis Vaccines and Diagnostics, Marburg, Germany, and Cambridge, MA, USAAbstract: Worldwide, invasive meningococcal disease affects about 500,000 people ...
Bröker M   +3 more
doaj  

Meningococcal Vaccines: Challenges and Prospects. [PDF]

open access: yesVaccines (Basel), 2020
Bagwe P   +5 more
europepmc   +1 more source

Meningococcal vaccines and protein-energy undernutrition in children in the African meningitis belt. [PDF]

open access: yesVaccine, 2020
Sundaram ME   +6 more
europepmc   +1 more source

Economic evaluation of meningococcal vaccines: considerations for the future. [PDF]

open access: yesEur J Health Econ, 2020
Christensen H   +17 more
europepmc   +1 more source

Meningococcal vaccine. From capsular polysaccharides of microbes to proteases

open access: yesRUDN Journal of Medicine, 2012
Microbial capsular polysaccharides for many years provided a highly practical public health vaccines for preventing meningococcal, pneumococcal and Haemophilus influenza infection, and typhoid fever.
A P Alliluyev   +12 more
doaj  

Meningococcal vaccines in Australia: a 2019 update. [PDF]

open access: yesAust Prescr, 2019
Sharma K, Chiu C, Wood N.
europepmc   +1 more source

Home - About - Disclaimer - Privacy